Quidel | QDEL - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
Agilent USD 6.91B 167M 2025-12
Avanos Medical USD 778.2M 200K 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Cerus USD 61.46M 6.04M 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Danaher USD 52.95B 415M 2026-03
Haemonetics USD 911.45M 62.28M 2025-12
Illumina USD 2.72B 342M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
Neogen USD 2.1B 2.09M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Quidel USD 1.92B 115.9M 2025-12
Revvity USD 7.38B 180.27M 2025-09
STAAR Surgical USD 344.18M 9.6M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Waters USD 2.56B 230.55M 2025-12